First Trust NASDAQ Cybersecurity ETF vs Centene Corp — how do they compare? First Trust NASDAQ Cybersecurity ETF trades at $94.9, while Centene Corp trades at $68.55 (market cap $33.72B). Which is the better fit depends on your goals.
| CIBR | CNC | |
|---|---|---|
52-Week High | $94.73 | $68.72 |
52-Week Low | $60.74 | $25.21 |
Market Cap | — | $33.72B |
Sector | — | Health |
Enterprise Value | — | $26.35B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
Trailing returns across standard periods
Latest headlines on both assets
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index includes securities of companies classified as cyber security companies. The fund is non-diversified.
Read more on CIBR →Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →